Inspire Medical Systems, Inc. Common Stock (INSP)
86.78
-4.13 (-4.54%)
NYSE · Last Trade: Nov 13th, 9:21 PM EST
Detailed Quote
| Previous Close | 90.91 |
|---|---|
| Open | 89.55 |
| Bid | 86.78 |
| Ask | 94.74 |
| Day's Range | 86.56 - 91.06 |
| 52 Week Range | 70.77 - 216.01 |
| Volume | 984,967 |
| Market Cap | 2.37B |
| PE Ratio (TTM) | 63.34 |
| EPS (TTM) | 1.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,193,304 |
Chart
About Inspire Medical Systems, Inc. Common Stock (INSP)
Inspire Medical Systems is a medical device company focused on developing innovative solutions to treat obstructive sleep apnea. The company specializes in the design and manufacturing of implantable neurostimulation devices that work to improve airflow during sleep by stimulating the hypoglossal nerve, which helps keep the airway open. Their technology aims to provide an effective alternative for individuals who are unable to tolerate traditional continuous positive airway pressure (CPAP) therapy. Through its pioneering approach, Inspire Medical Systems is committed to enhancing the quality of life for patients with sleep-disordered breathing conditions. Read More
News & Press Releases
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · November 13, 2025
LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · November 13, 2025
Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical “next generation” sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequent disastrous rollout that led to a dramatic stock crash.
By Hagens Berman · Via Business Wire · November 13, 2025
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of Pontiac Reestablished General Employees’ Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247 (D. Minn.), the Inspire Medical class action lawsuit charges Inspire Medical as well as certain of Inspire Medical’s top executives with violations of the Securities Exchange Act of 1934.
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · November 13, 2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · November 12, 2025
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · November 12, 2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stride, Inc. (NYSE:LRN), Firefly Aerospace Inc. (NASDAQ:FLY), Six Flags Entertainment Corporation (NYSE:FUN), and Inspire Medical Systems, Inc. (NYSE:INSP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · November 12, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 12, 2025
NEW YORK - November 12, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. (NYSE: INSP) of a class action securities lawsuit.
Via TheNewswire.com · November 12, 2025
PHILADELPHIA, Nov. 12, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · November 12, 2025
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.
Via StockStory · November 11, 2025
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · November 10, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · November 10, 2025
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · November 10, 2025
Law Offices of Howard G. Smith announces an investigation on behalf of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · November 10, 2025
The Law Offices of Frank R. Cruz announces an investigation of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By The Law Offices of Frank R. Cruz · Via Business Wire · November 10, 2025
Inspire Medical Systems’ third quarter results were well received by the market, supported by robust adoption of the Inspire V system and operational discipline. Management highlighted that growth was primarily driven by increased patient volume, positive clinical feedback, and continued expansion of the U.S. and international customer base. CEO Tim Herbert emphasized, “We are excited and energized by the strong performance of the Inspire V system and the clinical feedback on the simplified procedure and comfort settings has been tremendously positive.” The company also benefited from higher gross margins due to favorable product mix, despite increased marketing expenses.
Via StockStory · November 10, 2025
PHILADELPHIA, Nov. 09, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · November 9, 2025
NEW YORK, Nov. 09, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · November 9, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · November 9, 2025
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”). Inspire Medical is a medical technology company.
By The Rosen Law Firm, P.A. · Via Business Wire · November 7, 2025
NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) securities during the period of August 6, 2024 through August 4, 2025, inclusive (“the Class Period”).
By Kirby McInerney LLP · Via GlobeNewswire · November 7, 2025
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
By Faruqi & Faruqi, LLP · Via Business Wire · November 7, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire Medical (INSP) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 7, 2025
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of Pontiac Reestablished General Employees’ Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247 (D. Minn.), the Inspire Medical class action lawsuit charges Inspire Medical and certain of Inspire Medical’s top executives with violations of the Securities Exchange Act of 1934.
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · November 7, 2025